China Shineway Pharmaceutical Group Limited

SHSC:2877 Stock Report

Market Cap: HK$7.1b

China Shineway Pharmaceutical Group Management

Management criteria checks 1/4

We currently do not have sufficient information about the CEO.

Key information

Chief executive officer

n/a

Total compensation

CEO salary percentagen/a
CEO tenureno data
CEO ownershipn/a
Management average tenureno data
Board average tenure3.5yrs

Recent management updates

Recent updates


CEO

China Shineway Pharmaceutical Group has no CEO, or we have no data on them.


Board Members

NamePositionTenureCompensationOwnership
Zhenjiang Li
Co-Founder & Executive Chairman21.5yrsCN¥4.46m72.39%
CN¥ 5.1b
Yunxia Xin
Co-Founder & Executive Director19.8yrsCN¥3.11m0.071%
CN¥ 5.0m
Huimin Li
Executive Director19.8yrsCN¥2.09m0.14%
CN¥ 9.5m
Shun Fai Liu
Independent Non-Executive Director2.4yrsCN¥138.00kno data
Guihua Wang
Independent Non-Executive Directorless than a yearno datano data
Wencheng Zhou
Non-Executive Director3.5yrsCN¥138.00kno data
Yat On Yew
Independent Non-Executive Director1.5yrsCN¥35.00kno data

3.5yrs

Average Tenure

55yo

Average Age

Experienced Board: 2877's board of directors are considered experienced (3.5 years average tenure).


Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.